Literature DB >> 23624793

Which is the best surgical approach for anorectal gastrointestinal stromal tumors in the post-imatinib era?

S Pucciarelli1, I Maretto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23624793     DOI： 10.1007/s10151-013-1015-x

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  14 in total

1.  Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P G Casali; J-Y Blay
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

2.  Transvaginal excision of a large rectal stromal tumor: an alternative.

Authors:  Minia Hellan; Vijay K Maker
Journal:  Am J Surg       Date:  2006-01       Impact factor: 2.565

3.  Transanal endoscopic microsurgery after neoadjuvant therapy for rectal GIST.

Authors:  Alberto Arezzo; Mauro Verra; Mario Morino
Journal:  Dig Liver Dis       Date:  2011-07-22       Impact factor: 4.088

4.  Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.

Authors:  Jens Jakob; Chiara Mussi; Ulrich Ronellenfitsch; Eva Wardelmann; Tiziana Negri; Alessandro Gronchi; Peter Hohenberger
Journal:  Ann Surg Oncol       Date:  2012-09-11       Impact factor: 5.344

5.  Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach.

Authors:  Abbas Agaimy; Nikolaos Vassos; Bruno Märkl; Norbert Meidenbauer; Jens Köhler; Johann Spatz; Werner Hohenberger; Florian Haller; Roland S Croner; Regine Schneider-Stock; Klaus Matzel
Journal:  Int J Colorectal Dis       Date:  2013-02-13       Impact factor: 2.571

6.  Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.

Authors:  Burton L Eisenberg; Jonathan Harris; Charles D Blanke; George D Demetri; Michael C Heinrich; James C Watson; John P Hoffman; Scott Okuno; John M Kane; Margaret von Mehren
Journal:  J Surg Oncol       Date:  2009-01-01       Impact factor: 3.454

7.  Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors.

Authors:  D Centonze; E Pulvirenti; A Pulvirenti D'Urso; S Franco; N Cinardi; G Giannone
Journal:  Tech Coloproctol       Date:  2013-01-30       Impact factor: 3.781

8.  Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial.

Authors:  Aurore Blesius; Philippe A Cassier; François Bertucci; Jerome Fayette; Isabelle Ray-Coquard; Binh Bui; Antoine Adenis; Maria Rios; Didier Cupissol; David Pérol; Jean-Yves Blay; Axel Le Cesne
Journal:  BMC Cancer       Date:  2011-02-15       Impact factor: 4.430

9.  Transsacral approach to resect a gastrointestinal stromal tumor in the rectum: report of two cases.

Authors:  Kazuhide Matsushima; Munefumi Kayo
Journal:  Surg Today       Date:  2007-07-26       Impact factor: 2.540

10.  A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis.

Authors:  John C McAuliffe; Kelly K Hunt; Alexander J F Lazar; Haesun Choi; Wei Qiao; Peter Thall; Raphael E Pollock; Robert S Benjamin; Jonathan C Trent
Journal:  Ann Surg Oncol       Date:  2008-10-25       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.